109 related articles for article (PubMed ID: 25426995)
1. Dramatic response to itraconazole in central nervous system aspergillosis complicating acute promyelocytic leukemia.
Peng HL; Yi YF; Shen XH; Yin YF; Zhang GS
Infect Dis (Lond); 2015 Feb; 47(2):104-6. PubMed ID: 25426995
[TBL] [Abstract][Full Text] [Related]
2. Poor efficacy of amphotericin B-based therapy in CNS aspergillosis.
Schwartz S; Ruhnke M; Ribaud P; Reed E; Troke P; Thiel E
Mycoses; 2007 May; 50(3):196-200. PubMed ID: 17472616
[TBL] [Abstract][Full Text] [Related]
3. Itraconazole for the treatment of pulmonary aspergillosis in heart transplant recipients.
Nanas JN; Saroglou G; Anastasiou-Nana MI; Kostis EB; Petrochilou-Paschou VP; Kontoyannis DA; Stamatelopoulos SF; Moulopoulos SD
Clin Transplant; 1998 Feb; 12(1):30-4. PubMed ID: 9541420
[TBL] [Abstract][Full Text] [Related]
4. [Invasive pulmonary aspergillosis caused by Aspergillus ochraceus].
Wierzbicka M; Podsiadło B; Janczarski M
Pneumonol Alergol Pol; 1997; 65(3-4):254-60. PubMed ID: 9489424
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment using peroral itraconazole in a patient with acute promyelocytic leukemia complicated with splenic candidiasis.
Kumura T; Hino M; Nakao T; Yamane T; Ohta K; Wakasa K; Takubo T; Tatsumi N
Osaka City Med J; 1999 Jun; 45(1):9-13. PubMed ID: 10723197
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy of micafungin for chronic pulmonary aspergillosis.
Izumikawa K; Ohtsu Y; Kawabata M; Takaya H; Miyamoto A; Sakamoto S; Kishi K; Tsuboi E; Homma S; Yoshimura K
Med Mycol; 2007 May; 45(3):273-8. PubMed ID: 17464848
[TBL] [Abstract][Full Text] [Related]
7. [Case of pulmonary aspergillosis successfully treated with itraconazole].
Watanabe T; Kuriyama K; Kamei K
Jpn J Antibiot; 2000 Feb; 53(2):103-6; discussion 106-7. PubMed ID: 10896537
[No Abstract] [Full Text] [Related]
8. Itraconazole prophylaxis for invasive gingival aspergillosis in neutropenic patients with acute leukemia.
Myoken Y; Sugata T; Kyo T; Fujihara M; Mikami Y
J Periodontol; 2002 Jan; 73(1):33-8. PubMed ID: 11846198
[TBL] [Abstract][Full Text] [Related]
9. Invasive pulmonary and cerebral aspergillosis in a patient with Weil's disease.
Cocchi S; Codeluppi M; Guaraldi G; Squillace N; Bedini A; Venturelli C; Esposito R
Scand J Infect Dis; 2005; 37(5):396-8. PubMed ID: 16051585
[TBL] [Abstract][Full Text] [Related]
10. Caspofungin in combination with itraconazole for the treatment of invasive aspergillosis in humans.
Rubin MA; Carroll KC; Cahill BC
Clin Infect Dis; 2002 Apr; 34(8):1160-1. PubMed ID: 11915012
[No Abstract] [Full Text] [Related]
11. Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin.
Raad II; Hanna HA; Boktour M; Jiang Y; Torres HA; Afif C; Kontoyiannis DP; Hachem RY
Leukemia; 2008 Mar; 22(3):496-503. PubMed ID: 18094720
[TBL] [Abstract][Full Text] [Related]
12. Combined anti-fungal therapy and surgical resection as treatment of disseminated aspergillosis of the lung and brain following BMT.
Trigg ME; Menezes AH; Giller R; Lanza L; Smith RJ; Sato Y; Peters C; Altman A
Bone Marrow Transplant; 1993 Jun; 11(6):493-6. PubMed ID: 8392887
[TBL] [Abstract][Full Text] [Related]
13. CNS-aspergillosis: are there new treatment options?
Schwartz S; Thiel E
Mycoses; 2003; 46 Suppl 2():8-14. PubMed ID: 15055138
[TBL] [Abstract][Full Text] [Related]
14. Combination and sequential antifungal therapy for invasive aspergillosis: review of published in vitro and in vivo interactions and 6281 clinical cases from 1966 to 2001.
Steinbach WJ; Stevens DA; Denning DW
Clin Infect Dis; 2003 Oct; 37 Suppl 3():S188-224. PubMed ID: 12975752
[TBL] [Abstract][Full Text] [Related]
15. [Four cases of pulmonary aspergilloma successfully treated with drug therapy].
Kawana A
Jpn J Antibiot; 2000 Feb; 53(2):91-100; discussion 100-2. PubMed ID: 10896541
[No Abstract] [Full Text] [Related]
16. Successful management of postpneumonectomy Aspergillus pleural empyema by combined surgical and anti-fungal treatment with voriconazole and caspofungin.
Bonatti H; Lass-Floerl C; Angerer K; Singh N; Lechner M; Stelzmueller I; Singh R; Schmid T; Geltner C
Mycoses; 2010 Sep; 53(5):448-54. PubMed ID: 19496935
[TBL] [Abstract][Full Text] [Related]
17. A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients.
Oren I; Rowe JM; Sprecher H; Tamir A; Benyamini N; Akria L; Gorelik A; Dally N; Zuckerman T; Haddad N; Fineman R; Dann EJ
Bone Marrow Transplant; 2006 Jul; 38(2):127-34. PubMed ID: 16751782
[TBL] [Abstract][Full Text] [Related]
18. Caspofungin: new preparation. A last resort in invasive aspergillosis.
Prescrire Int; 2002 Oct; 11(61):142-3. PubMed ID: 12378745
[TBL] [Abstract][Full Text] [Related]
19. Rapid improvement of disseminated aspergillosis with caspofungin/voriconazole combination in an adult leukemic patient.
Damaj G; Ivanov V; Le Brigand B; D'incan E; Doglio MF; Bilger K; Faucher C; Vey N; Gastaut JA
Ann Hematol; 2004 Jun; 83(6):390-3. PubMed ID: 14666380
[TBL] [Abstract][Full Text] [Related]
20. Superiority of voriconazole over amphotericin B in the treatment of invasive aspergillosis after heart transplantation.
Wieland T; Liebold A; Jagiello M; Retzl G; Birnbaum DE
J Heart Lung Transplant; 2005 Jan; 24(1):102-4. PubMed ID: 15653389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
